Items home
EnglishFrenchDutchSpanishGermanItalianChineseTurkishPolishUSA

EQA Programmes

A sample list of molecular EQA programmes available from QCMD is displayed below. For further information, to register or to access our catalogue please login to your QCMD Laboratory Profile. If you do not have a Username and Password please click here.

Click to view / hide
Blood Borne Virus

B19 virus DNA EQA Programme

FeatureAvailable Formats
Catalogue NumberQAV034116_1QAV034116_2
Total Number of Challenges12
Number of Panel Members84
Distribution / Testing PeriodQ3Q1 & Q3

HBV Drug Resistance Typing EQA Programme

FeatureAvailable Formats
Catalogue NumberQAV124160_1
Total Number of Challenges1
Number of Panel Members5
Distribution / Testing PeriodQ3

HCV Drug Resistance Typing EQA Programme

FeatureAvailable Formats
Catalogue NumberQAV134167_1
Total Number of Challenges1
Number of Panel Members5
Distribution / Testing PeriodQ3

HIV Dried Blood Spot EQA Pilot Study

FeatureAvailable Formats
Catalogue NumberQAV214221_1
Total Number of Challenges1
Number of Panel Members8
Distribution / Testing PeriodQ4

HIV Drug Resistance EQA Programme

FeatureAvailable Formats
Catalogue NumberQAV024131_1
Total Number of Challenges1
Number of Panel Members5
Distribution / Testing PeriodQ3

HIV Drug Resistance (Integrase) EQA Programme

FeatureAvailable Formats
Catalogue NumberQAV114146_1
Total Number of Challenges1
Number of Panel Members5
Distribution / Testing PeriodQ3

HIV-1 DNA EQA programme

FeatureAvailable Formats
Catalogue NumberQAV034114_1QAV034114_2
Total Number of Challenges12
Number of Panel Members84
Distribution / Testing PeriodQ3Q1 & Q3

Hepatitis A virus RNA EQA Programme

FeatureAvailable Formats
Catalogue NumberQAV124156_1QAV124156_2
Total Number of Challenges12
Number of Panel Members84
Distribution / Testing PeriodQ3Q1 & Q3

Hepatitis B Virus DNA EQA Programme

FeatureAvailable Formats
Catalogue NumberQAV994110_1QAV994110_2QAV994110_4
Total Number of Challenges124
Number of Panel Members844
Distribution / Testing PeriodQ3Q1 & Q3Q1, Q2, Q3 & Q4

Hepatitis B Virus Dried Blood Spot EQA Pilot Study

FeatureAvailable Formats
Catalogue NumberQAV214223_1
Total Number of Challenges1
Number of Panel Members8
Distribution / Testing PeriodQ4

Hepatitis B virus Genotype EQA Programme

FeatureAvailable Formats
Catalogue NumberQAV064118_1
Total Number of Challenges1
Number of Panel Members8
Distribution / Testing PeriodQ1

Hepatitis C Virus Dried Blood Spot EQA Pilot Study

FeatureAvailable Formats
Catalogue NumberQAV214222_1
Total Number of Challenges1
Number of Panel Members8
Distribution / Testing PeriodQ4

Hepatitis C Virus RNA EQA Programme

FeatureAvailable Formats
Catalogue NumberQAV994112_1QAV994112_2QAV994112_4
Total Number of Challenges124
Number of Panel Members844
Distribution / Testing PeriodQ3Q1 & Q3Q1, Q2, Q3 & Q4

Hepatitis C virus Genotype EQA Programme

FeatureAvailable Formats
Catalogue NumberQAV034117_1
Total Number of Challenges1
Number of Panel Members8
Distribution / Testing PeriodQ1

Hepatitis D Virus EQA Programme

FeatureAvailable Formats
Catalogue NumberQAV144170_1
Total Number of Challenges1
Number of Panel Members8
Distribution / Testing PeriodQ3

Hepatitis E virus RNA EQA Programme

FeatureAvailable Formats
Catalogue NumberQAV124157_1
Total Number of Challenges1
Number of Panel Members8
Distribution / Testing PeriodQ3

Human Immunodeficiency Virus RNA EQA Programme

FeatureAvailable Formats
Catalogue NumberQAV994108_1QAV994108_2QAV994108_4
Total Number of Challenges124
Number of Panel Members844
Distribution / Testing PeriodQ3Q1 & Q3Q1, Q2, Q3 & Q4

Human Immunodeficiency Virus Type 2 EQA Pilot Study

FeatureAvailable Formats
Catalogue NumberQAV204212_1QAV204212_2
Total Number of Challenges12
Number of Panel Members84
Distribution / Testing PeriodQ3Q1 & Q3
Click to view / hide
Central Nervous System

Arthropod-Borne Viruses EQA Programme

FeatureAvailable Formats
Catalogue NumberQAM194206_1
Total Number of Challenges1
Number of Panel Members10
Distribution / Testing PeriodQ4

BK virus DNA EQA Programme

FeatureAvailable Formats
Catalogue NumberQAV144166_1QAV144166_2
Total Number of Challenges12
Number of Panel Members105
Distribution / Testing PeriodQ3Q2 & Q3

Borrelia burgdorferi spp. DNA EQA Programme

FeatureAvailable Formats
Catalogue NumberQAB114147_1
Total Number of Challenges1
Number of Panel Members10
Distribution / Testing PeriodQ3

Central Nervous System I (Viral Meningitis and Encephalitis) EQA Programme

FeatureAvailable Formats
Catalogue NumberQAV174195_1QAV174195_2
Total Number of Challenges12
Number of Panel Members105
Distribution / Testing PeriodQ4Q2 & Q4

Central Nervous System II (Non-Viral Meningitis and Encephalitis) EQA Programme

FeatureAvailable Formats
Catalogue NumberQAM174196_1QAM174196_2
Total Number of Challenges12
Number of Panel Members105
Distribution / Testing PeriodQ4Q2 & Q4

Chikungunya Virus EQA Programme

FeatureAvailable Formats
Catalogue NumberQAV154175_1
Total Number of Challenges1
Number of Panel Members10
Distribution / Testing PeriodQ4

Dengue Virus RNA EQA Programme

FeatureAvailable Formats
Catalogue NumberQAV114148_1
Total Number of Challenges1
Number of Panel Members10
Distribution / Testing PeriodQ4

Enterovirus RNA EQA Programme

FeatureAvailable Formats
Catalogue NumberQAV984104_1QAV984104_2
Total Number of Challenges12
Number of Panel Members105
Distribution / Testing PeriodQ3Q1 & Q3

Enterovirus Typing EQA Programme

FeatureAvailable Formats
Catalogue NumberQAV164185_1
Total Number of Challenges1
Number of Panel Members8
Distribution / Testing PeriodQ1

Herpes Simplex Virus Drug Resistance EQA Programme

FeatureAvailable Formats
Catalogue NumberQAV164184_1
Total Number of Challenges1
Number of Panel Members5
Distribution / Testing PeriodQ1

Herpes simplex virus DNA EQA Programme

FeatureAvailable Formats
Catalogue NumberQAV994105_1QAV994105_2
Total Number of Challenges12
Number of Panel Members105
Distribution / Testing PeriodQ3Q1 & Q3

JC virus DNA EQA Programme

FeatureAvailable Formats
Catalogue NumberQAV074106_1QAV074106_2
Total Number of Challenges12
Number of Panel Members105
Distribution / Testing PeriodQ3Q2 & Q3

Measles and Mumps EQA Programme

FeatureAvailable Formats
Catalogue NumberQAV144171_1
Total Number of Challenges1
Number of Panel Members10
Distribution / Testing PeriodQ3

Parechovirus RNA EQA Programme

FeatureAvailable Formats
Catalogue NumberQAV114145_1QAV114145_2
Total Number of Challenges12
Number of Panel Members105
Distribution / Testing PeriodQ3Q1 & Q3

Toxoplasma gondii DNA EQA Programme

FeatureAvailable Formats
Catalogue NumberQAP044123_1QAP044123_2
Total Number of Challenges12
Number of Panel Members105
Distribution / Testing PeriodQ4Q2 & Q4

Varicella-Zoster virus DNA EQA Programme

FeatureAvailable Formats
Catalogue NumberQAV034103_1QAV034103_2
Total Number of Challenges12
Number of Panel Members105
Distribution / Testing PeriodQ3Q1 & Q3

West Nile Virus RNA EQA Programme

FeatureAvailable Formats
Catalogue NumberQAV104141_1
Total Number of Challenges1
Number of Panel Members10
Distribution / Testing PeriodQ4

Zika Virus EQA Programme

FeatureAvailable Formats
Catalogue NumberQAV164186_1
Total Number of Challenges1
Number of Panel Members10
Distribution / Testing PeriodQ4
Click to view / hide
Congenital Infections

Cytomegalovirus Dried Blood Spot EQA Programme

FeatureAvailable Formats
Catalogue NumberQAV064127_1
Total Number of Challenges1
Number of Panel Members8
Distribution / Testing PeriodQ4

Toxoplasma gondii DNA EQA Programme

FeatureAvailable Formats
Catalogue NumberQAP044123_1QAP044123_2
Total Number of Challenges12
Number of Panel Members105
Distribution / Testing PeriodQ4Q2 & Q4

Trypanosoma cruzi (Chagas disease) EQA Pilot Study

FeatureAvailable Formats
Catalogue NumberQAP214217_1
Total Number of Challenges1
Number of Panel Members10
Distribution / Testing PeriodQ4
Click to view / hide
Drug Resistance

Cytomegalovirus Drug Resistance Typing EQA Programme

FeatureAvailable Formats
Catalogue NumberQAV144169_1
Total Number of Challenges1
Number of Panel Members5
Distribution / Testing PeriodQ2

Extended Spectrum β-lactamase and Carbapenemase EQA Programme

FeatureAvailable Formats
Catalogue NumberQAB134162_1
Total Number of Challenges1
Number of Panel Members8
Distribution / Testing PeriodQ3

HBV Drug Resistance Typing EQA Programme

FeatureAvailable Formats
Catalogue NumberQAV124160_1
Total Number of Challenges1
Number of Panel Members5
Distribution / Testing PeriodQ3

HCV Drug Resistance Typing EQA Programme

FeatureAvailable Formats
Catalogue NumberQAV134167_1
Total Number of Challenges1
Number of Panel Members5
Distribution / Testing PeriodQ3

HIV Drug Resistance EQA Programme

FeatureAvailable Formats
Catalogue NumberQAV024131_1
Total Number of Challenges1
Number of Panel Members5
Distribution / Testing PeriodQ3

HIV Drug Resistance (Integrase) EQA Programme

FeatureAvailable Formats
Catalogue NumberQAV114146_1
Total Number of Challenges1
Number of Panel Members5
Distribution / Testing PeriodQ3

Herpes Simplex Virus Drug Resistance EQA Programme

FeatureAvailable Formats
Catalogue NumberQAV164184_1
Total Number of Challenges1
Number of Panel Members5
Distribution / Testing PeriodQ1

Methicillin Resistant Staphylococcus aureus DNA EQA Programme

FeatureAvailable Formats
Catalogue NumberQAB064124_1
Total Number of Challenges1
Number of Panel Members10
Distribution / Testing PeriodQ4

Mycobacterium Tuberculosis Drug Resistance EQA Programme

FeatureAvailable Formats
Catalogue NumberQAB194209_1
Total Number of Challenges1
Number of Panel Members8
Distribution / Testing PeriodQ4

Vancomycin Resistant Enterococci EQA Programme

FeatureAvailable Formats
Catalogue NumberQAB134163_1
Total Number of Challenges1
Number of Panel Members10
Distribution / Testing PeriodQ3
Click to view / hide
Exotic / Emerging Diseases

Plasmodium spp. (Malaria) EQA Pilot Study

FeatureAvailable Formats
Catalogue NumberQAP214218_1
Total Number of Challenges1
Number of Panel Members10
Distribution / Testing PeriodQ4

Arthropod-Borne Viruses EQA Programme

FeatureAvailable Formats
Catalogue NumberQAM194206_1
Total Number of Challenges1
Number of Panel Members10
Distribution / Testing PeriodQ4

Babesia spp. (Babesiosis) EQA Pilot Study

FeatureAvailable Formats
Catalogue NumberQAP214219_1
Total Number of Challenges1
Number of Panel Members10
Distribution / Testing PeriodQ4

Chikungunya Virus EQA Programme

FeatureAvailable Formats
Catalogue NumberQAV154175_1
Total Number of Challenges1
Number of Panel Members10
Distribution / Testing PeriodQ4

Dengue Virus RNA EQA Programme

FeatureAvailable Formats
Catalogue NumberQAV114148_1
Total Number of Challenges1
Number of Panel Members10
Distribution / Testing PeriodQ4

Francisella tularensis EQA Pilot Study

FeatureAvailable Formats
Catalogue NumberQAB214220_1
Total Number of Challenges1
Number of Panel Members10
Distribution / Testing PeriodQ4

MERS Coronavirus EQA Programme

FeatureAvailable Formats
Catalogue NumberQAV154181_1
Total Number of Challenges1
Number of Panel Members8
Distribution / Testing PeriodQ2

Respiratory I Plus EQA Pilot Study

FeatureAvailable Formats
Catalogue NumberQAM204216_1
Total Number of Challenges1
Number of Panel Members10
Distribution / Testing PeriodQ3

SARS-CoV-2 Antigen Testing EQA Pilot Study

FeatureAvailable Formats
Catalogue NumberQAS214224_1AQAS214224_1BQAS214224_1C
Total Number of Challenges111
Number of Panel Members333
Distribution / Testing PeriodQ2Q3Q4

SARS-CoV-2 EQA Programme

FeatureAvailable Formats
Catalogue NumberQAV204215_1AQAV204215_1BQAV204215_1CQAV204215_1D
Total Number of Challenges1111
Number of Panel Members5555
Distribution / Testing PeriodQ1Q2Q3Q4

Trypanosoma cruzi (Chagas disease) EQA Pilot Study

FeatureAvailable Formats
Catalogue NumberQAP214217_1
Total Number of Challenges1
Number of Panel Members10
Distribution / Testing PeriodQ4

West Nile Virus RNA EQA Programme

FeatureAvailable Formats
Catalogue NumberQAV104141_1
Total Number of Challenges1
Number of Panel Members10
Distribution / Testing PeriodQ4

Yellow Fever Virus EQA Programme

FeatureAvailable Formats
Catalogue NumberQAV194207_1
Total Number of Challenges1
Number of Panel Members8
Distribution / Testing PeriodQ4

Zika Virus EQA Programme

FeatureAvailable Formats
Catalogue NumberQAV164186_1
Total Number of Challenges1
Number of Panel Members10
Distribution / Testing PeriodQ4
Click to view / hide
Gastrointestinal Diseases

Adenovirus DNA EQA Programme

FeatureAvailable Formats
Catalogue NumberQAV054133_1QAV054133_2
Total Number of Challenges12
Number of Panel Members105
Distribution / Testing PeriodQ3Q2 & Q3

Bacterial Gastroenteritis EQA Programme

FeatureAvailable Formats
Catalogue NumberQAB124153_1QAB124153_2
Total Number of Challenges12
Number of Panel Members105
Distribution / Testing PeriodQ4Q2 & Q4

Clostridium difficile DNA EQA Programme

FeatureAvailable Formats
Catalogue NumberQAB084125_1QAB084125_2
Total Number of Challenges12
Number of Panel Members105
Distribution / Testing PeriodQ4Q2 & Q4

Diarrheagenic Escherichia coli EQA Programme

FeatureAvailable Formats
Catalogue NumberQAB154179_1
Total Number of Challenges1
Number of Panel Members8
Distribution / Testing PeriodQ4

Helicobacter pylori EQA Programme

FeatureAvailable Formats
Catalogue NumberQAB164190_1
Total Number of Challenges1
Number of Panel Members10
Distribution / Testing PeriodQ3

Norovirus RNA EQA Programme

FeatureAvailable Formats
Catalogue NumberQAV084139_1QAV084139_2
Total Number of Challenges12
Number of Panel Members105
Distribution / Testing PeriodQ4Q2 & Q4

Parasitic Gastroenteritis EQA Programme

FeatureAvailable Formats
Catalogue NumberQAP124154_1QAP124154_2
Total Number of Challenges12
Number of Panel Members105
Distribution / Testing PeriodQ4Q2 & Q4

Viral Gastroenteritis EQA Programme

FeatureAvailable Formats
Catalogue NumberQAV124152_1QAV124152_2
Total Number of Challenges12
Number of Panel Members105
Distribution / Testing PeriodQ4Q2 & Q4
Click to view / hide
Immunocompromised Associated Diseases

Aspergillus spp. DNA EQA Programme

FeatureAvailable Formats
Catalogue NumberQAF104140_1
Total Number of Challenges1
Number of Panel Members8
Distribution / Testing PeriodQ3

BK virus DNA EQA Programme

FeatureAvailable Formats
Catalogue NumberQAV144166_1QAV144166_2
Total Number of Challenges12
Number of Panel Members105
Distribution / Testing PeriodQ3Q2 & Q3

Babesia spp. (Babesiosis) EQA Pilot Study

FeatureAvailable Formats
Catalogue NumberQAP214219_1
Total Number of Challenges1
Number of Panel Members10
Distribution / Testing PeriodQ4

Candida spp. EQA Programme

FeatureAvailable Formats
Catalogue NumberQAF124151_1
Total Number of Challenges1
Number of Panel Members10
Distribution / Testing PeriodQ3

Cytomegalovirus Drug Resistance Typing EQA Programme

FeatureAvailable Formats
Catalogue NumberQAV144169_1
Total Number of Challenges1
Number of Panel Members5
Distribution / Testing PeriodQ2

Cytomegalovirus Whole Blood EQA Programme

FeatureAvailable Formats
Catalogue NumberQAV124150_1QAV124150_2
Total Number of Challenges12
Number of Panel Members105
Distribution / Testing PeriodQ3Q2 & Q3

Epstein-Barr virus DNA EQA Programme

FeatureAvailable Formats
Catalogue NumberQAV024121_1QAV024121_2
Total Number of Challenges12
Number of Panel Members105
Distribution / Testing PeriodQ3Q2 & Q3

Epstein-Barr virus Whole Blood EQA Programme

FeatureAvailable Formats
Catalogue NumberQAV134161_1QAV134161_2
Total Number of Challenges12
Number of Panel Members105
Distribution / Testing PeriodQ3Q2 & Q3

Human Cytomegalovirus DNA EQA Programme

FeatureAvailable Formats
Catalogue NumberQAV014120_1QAV014120_2
Total Number of Challenges12
Number of Panel Members105
Distribution / Testing PeriodQ3Q2 & Q3

Human Herpes Virus 6 DNA EQA Programme

FeatureAvailable Formats
Catalogue NumberQAV084119_1QAV084119_2
Total Number of Challenges12
Number of Panel Members105
Distribution / Testing PeriodQ3Q2 & Q3

JC virus DNA EQA Programme

FeatureAvailable Formats
Catalogue NumberQAV074106_1QAV074106_2
Total Number of Challenges12
Number of Panel Members105
Distribution / Testing PeriodQ3Q2 & Q3

Pneumocystis jirovecii pneumonia (PCP) DNA EQA Programme

FeatureAvailable Formats
Catalogue NumberQAF114144_1
Total Number of Challenges1
Number of Panel Members10
Distribution / Testing PeriodQ3

Torque Teno Virus EQA Programme

FeatureAvailable Formats
Catalogue NumberQAV184203_1
Total Number of Challenges1
Number of Panel Members6
Distribution / Testing PeriodQ4

Toxoplasma gondii DNA EQA Programme

FeatureAvailable Formats
Catalogue NumberQAP044123_1QAP044123_2
Total Number of Challenges12
Number of Panel Members105
Distribution / Testing PeriodQ4Q2 & Q4

Transplantation EQA Programme

FeatureAvailable Formats
Catalogue NumberQAM174198_1QAM174198_2
Total Number of Challenges12
Number of Panel Members105
Distribution / Testing PeriodQ4Q2 & Q4

Trypanosoma cruzi (Chagas disease) EQA Pilot Study

FeatureAvailable Formats
Catalogue NumberQAP214217_1
Total Number of Challenges1
Number of Panel Members10
Distribution / Testing PeriodQ4
Click to view / hide
Multiple Pathogen/Syndromic

Arthropod-Borne Viruses EQA Programme

FeatureAvailable Formats
Catalogue NumberQAM194206_1
Total Number of Challenges1
Number of Panel Members10
Distribution / Testing PeriodQ4

Bacterial Gastroenteritis EQA Programme

FeatureAvailable Formats
Catalogue NumberQAB124153_1QAB124153_2
Total Number of Challenges12
Number of Panel Members105
Distribution / Testing PeriodQ4Q2 & Q4

Central Nervous System I (Viral Meningitis and Encephalitis) EQA Programme

FeatureAvailable Formats
Catalogue NumberQAV174195_1QAV174195_2
Total Number of Challenges12
Number of Panel Members105
Distribution / Testing PeriodQ4Q2 & Q4

Central Nervous System II (Non-Viral Meningitis and Encephalitis) EQA Programme

FeatureAvailable Formats
Catalogue NumberQAM174196_1QAM174196_2
Total Number of Challenges12
Number of Panel Members105
Distribution / Testing PeriodQ4Q2 & Q4

Chlamydia trachomatis and Neisseria gonorrhoeae DNA EQA Programme

FeatureAvailable Formats
Catalogue NumberQAB174191_1QAB174191_2
Total Number of Challenges12
Number of Panel Members105
Distribution / Testing PeriodQ3Q1 & Q3

MALDI-TOF EQA Programme

FeatureAvailable Formats
Catalogue NumberQAB124155_1
Total Number of Challenges1
Number of Panel Members10
Distribution / Testing PeriodQ3

Parasitic Gastroenteritis EQA Programme

FeatureAvailable Formats
Catalogue NumberQAP124154_1QAP124154_2
Total Number of Challenges12
Number of Panel Members105
Distribution / Testing PeriodQ4Q2 & Q4

Respiratory I EQA Programme

FeatureAvailable Formats
Catalogue NumberQAV164188_1QAV164188_2
Total Number of Challenges12
Number of Panel Members105
Distribution / Testing PeriodQ3Q1 & Q3

Respiratory I Plus EQA Pilot Study

FeatureAvailable Formats
Catalogue NumberQAM204216_1
Total Number of Challenges1
Number of Panel Members10
Distribution / Testing PeriodQ3

Respiratory II EQA Programme

FeatureAvailable Formats
Catalogue NumberQAV164189_1QAV164189_2
Total Number of Challenges12
Number of Panel Members105
Distribution / Testing PeriodQ3Q1 & Q3

Respiratory III EQA Programme

FeatureAvailable Formats
Catalogue NumberQAM174193_1QAM174193_2
Total Number of Challenges12
Number of Panel Members105
Distribution / Testing PeriodQ3Q1 & Q3

Sepsis EQA Programme

FeatureAvailable Formats
Catalogue NumberQAB164178_1
Total Number of Challenges1
Number of Panel Members10
Distribution / Testing PeriodQ4

Sexually Transmitted Infections I EQA Programme

FeatureAvailable Formats
Catalogue NumberQAB154177_1QAB154177_2
Total Number of Challenges12
Number of Panel Members105
Distribution / Testing PeriodQ3Q2 & Q3

Sexually Transmitted Infections II EQA Programme

FeatureAvailable Formats
Catalogue NumberQAM174201_1QAM174201_2
Total Number of Challenges12
Number of Panel Members105
Distribution / Testing PeriodQ3Q2 & Q3

Transplantation EQA Programme

FeatureAvailable Formats
Catalogue NumberQAM174198_1QAM174198_2
Total Number of Challenges12
Number of Panel Members105
Distribution / Testing PeriodQ4Q2 & Q4

Viral Gastroenteritis EQA Programme

FeatureAvailable Formats
Catalogue NumberQAV124152_1QAV124152_2
Total Number of Challenges12
Number of Panel Members105
Distribution / Testing PeriodQ4Q2 & Q4
Click to view / hide
Respiratory Diseases

Adenovirus DNA EQA Programme

FeatureAvailable Formats
Catalogue NumberQAV054133_1QAV054133_2
Total Number of Challenges12
Number of Panel Members105
Distribution / Testing PeriodQ3Q2 & Q3

Atypical Mycobacterium EQA Programme

FeatureAvailable Formats
Catalogue NumberQAB194208_1
Total Number of Challenges1
Number of Panel Members10
Distribution / Testing PeriodQ2

Bordetella pertussis DNA EQA Programme

FeatureAvailable Formats
Catalogue NumberQAB094132_1
Total Number of Challenges1
Number of Panel Members10
Distribution / Testing PeriodQ2

Chlamydia psittaci EQA Programme

FeatureAvailable Formats
Catalogue NumberQAB134165_1
Total Number of Challenges1
Number of Panel Members8
Distribution / Testing PeriodQ2

Chlamydophila pneumoniae EQA Programme

FeatureAvailable Formats
Catalogue NumberQAB084107_1
Total Number of Challenges1
Number of Panel Members5
Distribution / Testing PeriodQ2

Coronavirus RNA EQA Programme

FeatureAvailable Formats
Catalogue NumberQAV064137_1
Total Number of Challenges1
Number of Panel Members10
Distribution / Testing PeriodQ2

Influenza Typing EQA Programme

FeatureAvailable Formats
Catalogue NumberQAV064138_1
Total Number of Challenges1
Number of Panel Members8
Distribution / Testing PeriodQ4

Influenza virus A and B RNA EQA Programme

FeatureAvailable Formats
Catalogue NumberQAV054134_1QAV054134_2
Total Number of Challenges12
Number of Panel Members105
Distribution / Testing PeriodQ4Q2 & Q4

Legionella pneumophila DNA EQA Programme

FeatureAvailable Formats
Catalogue NumberQAB044122_1
Total Number of Challenges1
Number of Panel Members10
Distribution / Testing PeriodQ1

MERS Coronavirus EQA Programme

FeatureAvailable Formats
Catalogue NumberQAV154181_1
Total Number of Challenges1
Number of Panel Members8
Distribution / Testing PeriodQ2

Measles and Mumps EQA Programme

FeatureAvailable Formats
Catalogue NumberQAV144171_1
Total Number of Challenges1
Number of Panel Members10
Distribution / Testing PeriodQ3

Metapneumovirus RNA EQA Programme

FeatureAvailable Formats
Catalogue NumberQAV054135_1
Total Number of Challenges1
Number of Panel Members8
Distribution / Testing PeriodQ2

Mycobacterium Tuberculosis Drug Resistance EQA Programme

FeatureAvailable Formats
Catalogue NumberQAB194209_1
Total Number of Challenges1
Number of Panel Members8
Distribution / Testing PeriodQ4

Mycobacterium tuberculosis DNA EQA Programme

FeatureAvailable Formats
Catalogue NumberQAB014129_1QAB014129_2
Total Number of Challenges12
Number of Panel Members105
Distribution / Testing PeriodQ4Q2 & Q4

Mycoplasma pneumoniae EQA Programme

FeatureAvailable Formats
Catalogue NumberQAB174192_1
Total Number of Challenges1
Number of Panel Members5
Distribution / Testing PeriodQ2

Parainfluenza Virus RNA EQA Programme

FeatureAvailable Formats
Catalogue NumberQAV064136_1
Total Number of Challenges1
Number of Panel Members10
Distribution / Testing PeriodQ2

Pneumocystis jirovecii pneumonia (PCP) DNA EQA Programme

FeatureAvailable Formats
Catalogue NumberQAF114144_1
Total Number of Challenges1
Number of Panel Members10
Distribution / Testing PeriodQ3

Respiratory I EQA Programme

FeatureAvailable Formats
Catalogue NumberQAV164188_1QAV164188_2
Total Number of Challenges12
Number of Panel Members105
Distribution / Testing PeriodQ3Q1 & Q3

Respiratory I Plus EQA Pilot Study

FeatureAvailable Formats
Catalogue NumberQAM204216_1
Total Number of Challenges1
Number of Panel Members10
Distribution / Testing PeriodQ3

Respiratory II EQA Programme

FeatureAvailable Formats
Catalogue NumberQAV164189_1QAV164189_2
Total Number of Challenges12
Number of Panel Members105
Distribution / Testing PeriodQ3Q1 & Q3

Respiratory III EQA Programme

FeatureAvailable Formats
Catalogue NumberQAM174193_1QAM174193_2
Total Number of Challenges12
Number of Panel Members105
Distribution / Testing PeriodQ3Q1 & Q3

Respiratory Syncytial Virus RNA EQA Programme

FeatureAvailable Formats
Catalogue NumberQAV054142_1QAV054142_2
Total Number of Challenges12
Number of Panel Members105
Distribution / Testing PeriodQ4Q2 & Q4

Rhinovirus RNA EQA Programme

FeatureAvailable Formats
Catalogue NumberQAV064143_1
Total Number of Challenges1
Number of Panel Members10
Distribution / Testing PeriodQ2

SARS-CoV-2 Antigen Testing EQA Pilot Study

FeatureAvailable Formats
Catalogue NumberQAS214224_1AQAS214224_1BQAS214224_1C
Total Number of Challenges111
Number of Panel Members333
Distribution / Testing PeriodQ2Q3Q4

SARS-CoV-2 EQA Programme

FeatureAvailable Formats
Catalogue NumberQAV204215_1AQAV204215_1BQAV204215_1CQAV204215_1D
Total Number of Challenges1111
Number of Panel Members5555
Distribution / Testing PeriodQ1Q2Q3Q4
Click to view / hide
Sexually Transmitted Infections

Chlamydia trachomatis DNA EQA Programme

FeatureAvailable Formats
Catalogue NumberQAB004101_1QAB004101_2
Total Number of Challenges12
Number of Panel Members105
Distribution / Testing PeriodQ3Q1 & Q3

Chlamydia trachomatis and Neisseria gonorrhoeae DNA EQA Programme

FeatureAvailable Formats
Catalogue NumberQAB174191_1QAB174191_2
Total Number of Challenges12
Number of Panel Members105
Distribution / Testing PeriodQ3Q1 & Q3

Herpes Simplex Virus Drug Resistance EQA Programme

FeatureAvailable Formats
Catalogue NumberQAV164184_1
Total Number of Challenges1
Number of Panel Members5
Distribution / Testing PeriodQ1

Herpes simplex virus DNA EQA Programme

FeatureAvailable Formats
Catalogue NumberQAV994105_1QAV994105_2
Total Number of Challenges12
Number of Panel Members105
Distribution / Testing PeriodQ3Q1 & Q3

Human Papillomavirus (Preservcyt) EQA Programme

FeatureAvailable Formats
Catalogue NumberQAV094130_1QAV094130_2
Total Number of Challenges12
Number of Panel Members126
Distribution / Testing PeriodQ4Q2 & Q4

Human Papillomavirus (Surepath) EQA Programme

FeatureAvailable Formats
Catalogue NumberQAV184204_1
Total Number of Challenges1
Number of Panel Members12
Distribution / Testing PeriodQ4

Mycoplasma genitalium EQA Programme

FeatureAvailable Formats
Catalogue NumberQAB184205_1
Total Number of Challenges1
Number of Panel Members10
Distribution / Testing PeriodQ3

Neisseria gonorrhoeae DNA EQA Programme

FeatureAvailable Formats
Catalogue NumberQAB034126_1QAB034126_2
Total Number of Challenges12
Number of Panel Members105
Distribution / Testing PeriodQ3Q1 & Q3

Sexually Transmitted Infections I EQA Programme

FeatureAvailable Formats
Catalogue NumberQAB154177_1QAB154177_2
Total Number of Challenges12
Number of Panel Members105
Distribution / Testing PeriodQ3Q2 & Q3

Sexually Transmitted Infections II EQA Programme

FeatureAvailable Formats
Catalogue NumberQAM174201_1QAM174201_2
Total Number of Challenges12
Number of Panel Members105
Distribution / Testing PeriodQ3Q2 & Q3

Syphilis EQA Programme

FeatureAvailable Formats
Catalogue NumberQAB154180_1
Total Number of Challenges1
Number of Panel Members8
Distribution / Testing PeriodQ4

Trichomonas vaginalis EQA Programme

FeatureAvailable Formats
Catalogue NumberQAP184202_1
Total Number of Challenges1
Number of Panel Members8
Distribution / Testing PeriodQ3
Click to view / hide
Transplant Associated Diseases

Adenovirus DNA EQA Programme

FeatureAvailable Formats
Catalogue NumberQAV054133_1QAV054133_2
Total Number of Challenges12
Number of Panel Members105
Distribution / Testing PeriodQ3Q2 & Q3

BK virus DNA EQA Programme

FeatureAvailable Formats
Catalogue NumberQAV144166_1QAV144166_2
Total Number of Challenges12
Number of Panel Members105
Distribution / Testing PeriodQ3Q2 & Q3

Cytomegalovirus Drug Resistance Typing EQA Programme

FeatureAvailable Formats
Catalogue NumberQAV144169_1
Total Number of Challenges1
Number of Panel Members5
Distribution / Testing PeriodQ2

Cytomegalovirus Whole Blood EQA Programme

FeatureAvailable Formats
Catalogue NumberQAV124150_1QAV124150_2
Total Number of Challenges12
Number of Panel Members105
Distribution / Testing PeriodQ3Q2 & Q3

Epstein-Barr virus DNA EQA Programme

FeatureAvailable Formats
Catalogue NumberQAV024121_1QAV024121_2
Total Number of Challenges12
Number of Panel Members105
Distribution / Testing PeriodQ3Q2 & Q3

Epstein-Barr virus Whole Blood EQA Programme

FeatureAvailable Formats
Catalogue NumberQAV134161_1QAV134161_2
Total Number of Challenges12
Number of Panel Members105
Distribution / Testing PeriodQ3Q2 & Q3

Human Cytomegalovirus DNA EQA Programme

FeatureAvailable Formats
Catalogue NumberQAV014120_1QAV014120_2
Total Number of Challenges12
Number of Panel Members105
Distribution / Testing PeriodQ3Q2 & Q3

Human Herpes Virus 6 DNA EQA Programme

FeatureAvailable Formats
Catalogue NumberQAV084119_1QAV084119_2
Total Number of Challenges12
Number of Panel Members105
Distribution / Testing PeriodQ3Q2 & Q3

JC virus DNA EQA Programme

FeatureAvailable Formats
Catalogue NumberQAV074106_1QAV074106_2
Total Number of Challenges12
Number of Panel Members105
Distribution / Testing PeriodQ3Q2 & Q3

Torque Teno Virus EQA Programme

FeatureAvailable Formats
Catalogue NumberQAV184203_1
Total Number of Challenges1
Number of Panel Members6
Distribution / Testing PeriodQ4

Toxoplasma gondii DNA EQA Programme

FeatureAvailable Formats
Catalogue NumberQAP044123_1QAP044123_2
Total Number of Challenges12
Number of Panel Members105
Distribution / Testing PeriodQ4Q2 & Q4

Transplantation EQA Programme

FeatureAvailable Formats
Catalogue NumberQAM174198_1QAM174198_2
Total Number of Challenges12
Number of Panel Members105
Distribution / Testing PeriodQ4Q2 & Q4
Click to view / hide
Typing

Bacterial 16S EQA Programme

FeatureAvailable Formats
Catalogue NumberQAB164183_1
Total Number of Challenges1
Number of Panel Members8
Distribution / Testing PeriodQ4

Cytomegalovirus Drug Resistance Typing EQA Programme

FeatureAvailable Formats
Catalogue NumberQAV144169_1
Total Number of Challenges1
Number of Panel Members5
Distribution / Testing PeriodQ2

Enterovirus Typing EQA Programme

FeatureAvailable Formats
Catalogue NumberQAV164185_1
Total Number of Challenges1
Number of Panel Members8
Distribution / Testing PeriodQ1

HBV Drug Resistance Typing EQA Programme

FeatureAvailable Formats
Catalogue NumberQAV124160_1
Total Number of Challenges1
Number of Panel Members5
Distribution / Testing PeriodQ3

HCV Drug Resistance Typing EQA Programme

FeatureAvailable Formats
Catalogue NumberQAV134167_1
Total Number of Challenges1
Number of Panel Members5
Distribution / Testing PeriodQ3

HIV Drug Resistance EQA Programme

FeatureAvailable Formats
Catalogue NumberQAV024131_1
Total Number of Challenges1
Number of Panel Members5
Distribution / Testing PeriodQ3

HIV Drug Resistance (Integrase) EQA Programme

FeatureAvailable Formats
Catalogue NumberQAV114146_1
Total Number of Challenges1
Number of Panel Members5
Distribution / Testing PeriodQ3

Hepatitis B virus Genotype EQA Programme

FeatureAvailable Formats
Catalogue NumberQAV064118_1
Total Number of Challenges1
Number of Panel Members8
Distribution / Testing PeriodQ1

Hepatitis C virus Genotype EQA Programme

FeatureAvailable Formats
Catalogue NumberQAV034117_1
Total Number of Challenges1
Number of Panel Members8
Distribution / Testing PeriodQ1

Herpes Simplex Virus Drug Resistance EQA Programme

FeatureAvailable Formats
Catalogue NumberQAV164184_1
Total Number of Challenges1
Number of Panel Members5
Distribution / Testing PeriodQ1

Influenza Typing EQA Programme

FeatureAvailable Formats
Catalogue NumberQAV064138_1
Total Number of Challenges1
Number of Panel Members8
Distribution / Testing PeriodQ4

MALDI-TOF EQA Programme

FeatureAvailable Formats
Catalogue NumberQAB124155_1
Total Number of Challenges1
Number of Panel Members10
Distribution / Testing PeriodQ3

Methicillin Resistant Staphylococcus aureus Typing (epidemiology and outbreak studies) EQA Programme

FeatureAvailable Formats
Catalogue NumberQAB074128_1
Total Number of Challenges1
Number of Panel Members8
Distribution / Testing PeriodQ4

Staphylococcus aureus spa EQA Programme

FeatureAvailable Formats
Catalogue NumberQAB134164_1
Total Number of Challenges1
Number of Panel Members6
Distribution / Testing PeriodQ4
Click to view / hide
EQA Pilots

Human Immunodeficiency Virus Type 2 EQA Pilot Study

FeatureAvailable Formats
Catalogue NumberQAV204212_1QAV204212_2
Total Number of Challenges12
Number of Panel Members84
Distribution / Testing PeriodQ3Q1 & Q3

Respiratory I Plus EQA Pilot Study

FeatureAvailable Formats
Catalogue NumberQAM204216_1
Total Number of Challenges1
Number of Panel Members10
Distribution / Testing PeriodQ3

SARS-CoV-2 Antigen Testing EQA Pilot Study

FeatureAvailable Formats
Catalogue NumberQAS214224_1AQAS214224_1BQAS214224_1C
Total Number of Challenges111
Number of Panel Members333
Distribution / Testing PeriodQ2Q3Q4

Viral Metagenomics NGS EQA Pilot Study

FeatureAvailable Formats
Catalogue NumberQAV204213_1
Total Number of Challenges1
Number of Panel Members5
Distribution / Testing PeriodQ4

Plasmodium spp. (Malaria) EQA Pilot Study

FeatureAvailable Formats
Catalogue NumberQAP214218_1
Total Number of Challenges1
Number of Panel Members10
Distribution / Testing PeriodQ4

Babesia spp. (Babesiosis) EQA Pilot Study

FeatureAvailable Formats
Catalogue NumberQAP214219_1
Total Number of Challenges1
Number of Panel Members10
Distribution / Testing PeriodQ4

Francisella tularensis EQA Pilot Study

FeatureAvailable Formats
Catalogue NumberQAB214220_1
Total Number of Challenges1
Number of Panel Members10
Distribution / Testing PeriodQ4

HIV Dried Blood Spot EQA Pilot Study

FeatureAvailable Formats
Catalogue NumberQAV214221_1
Total Number of Challenges1
Number of Panel Members8
Distribution / Testing PeriodQ4

Hepatitis B Virus Dried Blood Spot EQA Pilot Study

FeatureAvailable Formats
Catalogue NumberQAV214223_1
Total Number of Challenges1
Number of Panel Members8
Distribution / Testing PeriodQ4

Hepatitis C Virus Dried Blood Spot EQA Pilot Study

FeatureAvailable Formats
Catalogue NumberQAV214222_1
Total Number of Challenges1
Number of Panel Members8
Distribution / Testing PeriodQ4

Trypanosoma cruzi (Chagas disease) EQA Pilot Study

FeatureAvailable Formats
Catalogue NumberQAP214217_1
Total Number of Challenges1
Number of Panel Members10
Distribution / Testing PeriodQ4
Unit 5, Technology Terrace, Todd Campus, West of Scotland Science Park Glasgow G20 0XA Scotland, UK
Tel: +44 (0)141 945 6474 Fax: +44 (0)141 945 5795 Enquiry Form